Overview of Dr. Abu Zeinah
Dr. Ghaith Abu Zeinah is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from Weill Cornell Medical College in Qatar and has been in practice 3 years. He is one of 60 doctors at New York-Presbyterian Hospital and one of 60 doctors at New York-Presbyterian Hospital who specialize in Hematology. He also speaks multiple languages, including Arabic. He has more than 20 publications and over 350 citings.
Office
520 East 70th Street
Starr Pavilion, 3rd Floor
New York, NY 10021- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2016 - 2019
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2013 - 2016
- Weill Cornell Medical College in QatarClass of 2013
Certifications & Licensure
- NY State Medical License 2016 - 2025
- NJ State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Susan Murphy Fellow Award Weill Cornell Medicine, New York, NY, 2018
- Fellows Award in Research Department of Medicine, Weill Cornell Medicine, 2018
- Best Overall Abstract Award 11th International Congress on Myeloproliferative Neoplasms, 2018
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsNormal life expectancy for polycythemia vera (PV) patients is possible.Ghaith Abu-Zeinah, Richard T. Silver, Khalid Abu-Zeinah, Joseph M. Scandura> ;Leukemia. 2021 Oct 8
- 45 citationsInterferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival.Ghaith Abu-Zeinah, Spencer Krichevsky, Tatiana Cruz, Gabriela Hoberman, Diana Jaber, Niamh Savage, Claudia Sosner, Ellen K. Ritchie, Joseph M. Scandura, Richard T. Silver> ;Leukemia. 2021 Mar 2
- 4 citationsOutcomes in CLL patients with NOTCH1 regulatory pathway mutations.Daniel R. Helbig, Ghaith Abu-Zeinah, Erica B. Bhavsar, Paul J. Christos, Richard R. Furman, John N. Allan> ;American Journal of Hematology. 2021 Feb 24
- Join now to see all
Abstracts/Posters
- Molecular Genetics and Prognosis in Younger Patients with Chronic Lymphocytic Leukemia (CLL)Ghaith Abu Zeinah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Thrombotic Risk Factors, Antithrombotic Therapy, and Outcomes of Asymptomatic Carriers of Antiphospholipid Antibodies and Patients with Antiphospholipid SyndromeGhaith Abu-Zeinah, MD, Clara Oromendia, MS and Maria Teresa De Sancho, MD, American Society of Hematology, Atlanta, GA, 12/10/2017
- A Single Institutional Experience Comparing Cryoprecipitate to Plasma in Patients with Disseminated Intravascular Coagulopathy (DIC) from Acute Myeloid Leukemia (AML)Ghaith Abu-Zeinah, MD, Mustafa Al-Kawaaz, MD, Valery J Li, MD, Yen-Michael S. Hsu, MD, PhD, Melissa M. Cushing, MD and Joseph Scandura, MD, PhD, American Society of Hematology, Atlanta, GA, 12/9/2017
Research History
- Research FellowIdentifying therapeutic mechanisms in classical Myeloproliferative Neoplasms using an in vitro stem cell expansion platform2017 - 2019
- Co-investigatorTransition of Care for Patients with Venous Thromboembolism (VTE) at ATHN Affiliated Sites2016 - 2018
Professional Memberships
- Associate Member
- Member
Other Languages
- Arabic
Hospital Affiliations
- New York-Presbyterian HospitalNew York, New York
- New York-Presbyterian HospitalNew York, New York
- New York-Presbyterian HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: